Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline Prophylaxis for Open Fractures
NCT02937181Phase 4Unknown
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftaroline fosamil in fracture-related infection (FRI). Primary endpoint: Rate of fracture site infection at 30 days between ceftaroline and historical hospital rate. Status: unknown.
02
Drugs
ceftaroline fosamil
03
Conditions
fracture-related infection (FRI)
Beyond the preview
Go deeper on NCT02937181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937181.